Apple told the US Court of Appeals for the Federal Circuit that the US International Trade Commission's decision was based on a "series of substantively defective patent rulings," and that medical-monitoring technology company Masimo failed to show it had invested in making competing US products that would justify the order. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
